By A Web Design

The Tawam Molecular Imaging Centre (TMIC), brought to you by Mubadala Healthcare, is a world-class specialist molecular imaging facility, constructed by Siemens and clinically operated by Johns Hopkins Medicine International (JHI). The Centre features advanced PET.CT diagnostic imaging systems that are essential for the early detection and management of cancer, cardiovascular, neurological and other diseases.

The Tawam Molecular Imaging Centre is positioned on the Tawam Hospital Campus; the Al Ain based hospital renowned for its reputation as a leading regional oncology centre. Supporting the existing capabilities of the hospital, the Centre extends a continuum of quality healthcare to meet the growing need for the treatment and diagnosis of cancer and other diseases within both the UAE and surrounding GCC countries.
 

"PET.CT is the preferred diagnostic tool for nearly all types of cancer, suspected heart disease and for the assessment of neurological conditions."

 

 

 

Dr. Richard L. Wahl, M.D
Director,
Division of Nuclear Medicine/PET 
Professor of Radiology,
Johns Hopkins Medicine
 

"Tawam Molecular Imaging Centre is the first purpose-built state of the art facility in the region to bring molecular imaging to people of the UAE, allowing for earlier diagnosis, accurate assessment of disease status and enhanced follow ups."

 

Dr. Muhammad Ali Chaudhry, M.D
Medical Director,
Tawam Molecular Imaging Centre
Clinical Assistant Professor of Radiology, Johns Hopkins Medicine
 

"The opening of Tawam Molecular Imaging Centre is a significant milestone in Mubadala Healthcare's plan to stimulate the development of Abu Dhabi's healthcare sector by setting the very highest standards in medical treatment and patient care."

 

Suhail Al Ansari
Executive Director,
Mubadala Healthcare
Chairman of the Board,
Tawam Molecular Imaging Centre